NCT01590407View on ClinicalTrials.gov

First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Hepatitis C, Chronic
Interventions
DRUG

ALS-002200

ALS-002200

DRUG

Placebo

Placebo

Trial Locations (4)

Unknown

Biotrial, Rennes

Biotrial, Paris

Arensia, Chisinau

Arensia, Bucharest

Sponsors
All Listed Sponsors
collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

Alios Biopharma Inc.

INDUSTRY